66
Participants
Start Date
May 24, 2019
Primary Completion Date
April 10, 2020
Study Completion Date
April 10, 2020
CTP-543
Administered as 12 mg tablets.
CTP-543 Matching Placebo
Administered as tablets to aid treatment masking.
ForCare Clinical Research, Tampa
The Indiana Clinical Trials Center, PC, Plainfield
Austin Institute for Clinical Research, Inc., Pflugerville
Colorado Center for Dermatology and Skin Surgery, Centennial
Massachusetts General Hospital, Boston
SimcoDerm Medical and Surgical Dermatology Center, Barrie
Guelph Dermatology Research, Guelph
Dr Wei Jing Loo Medicine Professional Corporation, London
Lynderm Research Inc., Markham
The Centre for Clinical Trials, Oakville
Research Toronto, Toronto
Innovaderm Research Inc., Montreal
Lead Sponsor
Concert Pharmaceuticals
INDUSTRY